humulene and Burkitt-Lymphoma

humulene has been researched along with Burkitt-Lymphoma* in 2 studies

Trials

1 trial(s) available for humulene and Burkitt-Lymphoma

ArticleYear
Current trends in clinical pharmacology in the USA.
    Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology, 1970, Volume: 4, Issue:1

    Topics: Animals; Asparaginase; Burkitt Lymphoma; Cannabis; Carcinogens; Clinical Trials as Topic; Contraceptives, Oral; Cyclamates; Cyclophosphamide; Cytarabine; Female; Humans; Legislation, Drug; Leukemia; Pharmacology; Psychology, Adolescent; Substance-Related Disorders; Thromboembolism; United States; United States Food and Drug Administration; Uterine Cervical Neoplasms

1970

Other Studies

1 other study(ies) available for humulene and Burkitt-Lymphoma

ArticleYear
Inhaled medicinal cannabis and the immunocompromised patient.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:3

    Medicinal cannabis is an invaluable adjunct therapy for pain relief, nausea, anorexia, and mood modification in cancer patients and is available as cookies or cakes, as sublingual drops, as a vaporized mist, or for smoking. However, as with every herb, various microorganisms are carried on its leaves and flowers which when inhaled could expose the user, in particular immunocompromised patients, to the risk of opportunistic lung infections, primarily from inhaled molds. The objective of this study was to identify the safest way of using medicinal cannabis in immunosuppressed patients by finding the optimal method of sterilization with minimal loss of activity of cannabis. We describe the results of culturing the cannabis herb, three methods of sterilization, and the measured loss of a main cannabinoid compound activity. Systematic sterilization of medicinal cannabis can eliminate the risk of fatal opportunistic infections associated with cannabis among patients at risk.

    Topics: Administration, Inhalation; Adult; Antineoplastic Agents; Aspergillosis; Aspergillus; Burkitt Lymphoma; Cannabis; Humans; Immunocompromised Host; Male; Medical Marijuana; Nausea; Opportunistic Infections; Pain Management; Phytotherapy; Sterilization; Vomiting; Young Adult

2015